On-pump versus off-pump coronary artery bypass grafting for left main coronary artery disease: long-term outcomes

Tae Oh Kim1, Min Jung Ku2, Sehee Kim3

  • 1Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Journal of Thoracic Disease
|September 15, 2025
PubMed

Insights

Off-pump coronary artery bypass grafting (CABG) in patients with left main coronary artery disease achieves similar long-term outcomes to on-pump CABG. This high-volume center study found comparable rates of death, myocardial infarction, or stroke within 5 years.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Minimally Invasive Cardiac Surgery

Background:

  • Inconsistent results exist comparing off-pump versus on-pump coronary artery bypass grafting (CABG), particularly for left main coronary artery disease (LM CAD).
  • Surgical expertise variations contribute to differing outcomes in previous studies.
  • This study leverages data from a high-volume center with extensive experience in both CABG techniques.

Purpose of the Study:

  • To compare the long-term efficacy and safety of off-pump versus on-pump CABG for patients with significant LM CAD.
  • To evaluate outcomes in a setting with standardized surgical expertise.

Main Methods:

  • Retrospective analysis of 1,410 patients with significant LM CAD undergoing isolated CABG (2003-2017).
  • Primary endpoint: composite of death, myocardial infarction (MI), or stroke within 5 years.
  • Statistical analyses included Cox regression, inverse probability of treatment weighting (IPTW), and propensity score (PS) matching.

Main Results:

  • Off-pump CABG (824 patients) showed a low conversion rate (1.0%) and high left internal mammary artery (LIMA) utilization (97.0%).
  • Five-year composite endpoint rates were similar: 14.7% (off-pump) vs. 15.0% (on-pump) (unadjusted HR: 0.98, 95% CI: 0.74-1.30), persisting after adjustments.
  • In-hospital composite outcomes were lower for off-pump CABG (1.3% vs. 3.5%, P=0.01).

Conclusions:

  • Off-pump CABG in LM CAD patients at a high-volume, experienced center yields long-term outcomes comparable to on-pump CABG.
  • The findings support off-pump CABG as a viable option for LM CAD.
  • Further prospective studies are needed to confirm results and refine patient selection criteria.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
597
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
288
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215